Suppr超能文献

洛贝林对大鼠而言并非强化物。

Lobeline does not serve as a reinforcer in rats.

作者信息

Harrod Steven B, Dwoskin Linda P, Green Thomas A, Gehrke Brenda J, Bardo Michael T

机构信息

Department of Psychology, University of Kentucky, 115 Kastle Hall, Lexington, KY 40506-0044, USA.

出版信息

Psychopharmacology (Berl). 2003 Feb;165(4):397-404. doi: 10.1007/s00213-002-1289-6. Epub 2002 Nov 30.

Abstract

RATIONALE

Previous results demonstrated that pretreatment with lobeline attenuates d-methamphetamine self-administration in rats.

OBJECTIVE

The present experiments determined if lobeline serves as a reinforcer, if it decreases d-methamphetamine-induced reinstatement of d-methamphetamine self-administration, and if it activates the mesolimbic and nigrostriatal dopamine (DA) pathways in Sprague-Dawley male rats.

METHODS

The ability of intravenous (IV) lobeline (0.015-0.15 mg/kg per infusion) to engender responding and the ability of lobeline (0.015 and 0.05 mg/kg per infusion) to substitute for d-methamphetamine was determined using the self-administration paradigm. Experiments were also performed to determine if lobeline (1.0 and 3.0 mg/kg) reinstates responding for d-methamphetamine or alters the ability of d-methamphetamine (1.0 mg/kg per infusion) to reinstate responding following extinction. The effect of lobeline (3.0 mg/kg) or d-methamphetamine (1.0 and 3.0 mg/kg) on DA and dihydroxyphenylacetic acid (DOPAC) levels in the nucleus accumbens and striatum were also determined.

RESULTS

Lobeline was not self-administered and did not substitute for d-methamphetamine. Also, lobeline did not reinstate responding for d-methamphetamine following extinction nor did it alter d-methamphetamine-induced reinstatement. Furthermore, lobeline did not alter DA or DOPAC levels in the either the nucleus accumbens or striatum.

CONCLUSIONS

Taken together, the present results indicate that lobeline decreases d-methamphetamine self-administration by decreasing reward, not by acting as a substitute reinforcer.

摘要

理论依据

先前的研究结果表明,用洛贝林预处理可减弱大鼠对右旋苯丙胺的自我给药行为。

目的

本实验旨在确定洛贝林是否为强化剂,是否能减少右旋苯丙胺诱导的右旋苯丙胺自我给药行为的恢复,以及是否能激活斯普拉格-道利雄性大鼠的中脑边缘和黑质纹状体多巴胺(DA)通路。

方法

采用自我给药范式,测定静脉注射(IV)洛贝林(每次输注0.015 - 0.15毫克/千克)产生反应的能力以及洛贝林(每次输注0.015和0.05毫克/千克)替代右旋苯丙胺的能力。还进行了实验,以确定洛贝林(1.0和3.0毫克/千克)是否能恢复对右旋苯丙胺的反应,或改变右旋苯丙胺(每次输注1.0毫克/千克)在消退后恢复反应的能力。还测定了洛贝林(3.0毫克/千克)或右旋苯丙胺(1.0和3.0毫克/千克)对伏隔核和纹状体中多巴胺(DA)和二羟基苯乙酸(DOPAC)水平的影响。

结果

洛贝林不能自我给药,也不能替代右旋苯丙胺。此外,洛贝林在消退后不能恢复对右旋苯丙胺的反应,也不会改变右旋苯丙胺诱导的反应恢复。此外,洛贝林不会改变伏隔核或纹状体中的多巴胺或DOPAC水平。

结论

综上所述,目前的结果表明,洛贝林通过降低奖赏来减少右旋苯丙胺的自我给药行为,而不是作为替代强化剂起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验